PV-267

N/A

Report date: 2024/12/05 14:02:00
NME

Base Information

Drug NamePV-267
Drug Alias NamePV-267
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHLA-DR antigens blockers
TargetsHLA-DR antigens
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProvid Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A